Back to Search
Start Over
"MIATA"-minimal information about T cell assays.
- Source :
-
Immunity [Immunity] 2009 Oct 16; Vol. 31 (4), pp. 527-8. - Publication Year :
- 2009
-
Abstract
- Immunotherapy, especially therapeutic vaccination, has a great deal of potential in the treatment of cancer and certain infectious diseases such as HIV (Allison et al., 2006; Fauci et al., 2008; Feldmann and Steinman, 2005). Numerous vaccine candidates have been tested in patients with a variety of tumor types and chronic viral diseases. Often, the best way to assess the clinical potential of these vaccines is to monitor the induced T cell response, and yet there are currently no standards for reporting these results. This letter is an effort to address this problem.
- Subjects :
- Cancer Vaccines immunology
Humans
Immunotherapy
Viral Vaccines immunology
Cancer Vaccines therapeutic use
Immunoassay standards
Monitoring, Immunologic standards
Neoplasms therapy
Practice Guidelines as Topic standards
T-Lymphocytes immunology
Viral Vaccines therapeutic use
Virus Diseases therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1097-4180
- Volume :
- 31
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Immunity
- Publication Type :
- Editorial & Opinion
- Accession number :
- 19833080
- Full Text :
- https://doi.org/10.1016/j.immuni.2009.09.007